Characterization of T-cell reactive epitopes in glycoprotein G of herpes simplex virus type 2 using synthetic peptides

Archives of Virology

Volumn 150, Issue 7, 2005, Pages 1393-1406

  Bellner, L ^a   Lowhagen G B ^b   Tunback P ^b,c   Nordstrom I ^a   Liljeqvist, J A ^c   Eriksson, K ^a,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN G, HERPES SIMPLEX VIRUS TYPE 2; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CHEMISTRY; FEMALE; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOLOGY; MALE;

ADULT; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES; FEMALE; HERPESVIRUS 2, HUMAN; HUMANS; MALE; VIRAL ENVELOPE PROTEINS;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2;

EID: 20544477978     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-005-0497-x     Document Type: Article

References (33)

1. Balachandran N, Hutt-Fletcher LM (1985) Synthesis and processing of glycoprotein gG of herpes simplex virus type 2. J Virol 54: 825-832
2. Beekman NJ, Schaaper WM, Turkstra JA, Meloen RH (1999) Highly immunogenic and fully synthetic peptide-carrier constructs targetting GnRH. Vaccine 17: 2043-2050
3. BenMohamed L, Bertrand G, McNamara CD, Gras-Masse H, Hammer J, Wechsler SL, Nesburn AB (2003) Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity. J Virol 77: 9463-9473
4. Bäcklund J, Treschow A, Bockermann R, Holm B, Holm L, Issazadeh-Navikas S, Kihlberg J, Holmdahl R (2002) Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis. Eur J Immunol 32: 3776-3784
5. Dall'Olio F, Malagolini N, Campadelli-Fiume G, Serafini-Cessi F (1987) Glycosylation pattern of herpes simplex virus type 2 glycoprotein G from precursor species to the mature form. Arch Virol 97: 237-249
6. Deck MB, Sjolin P, Unanue ER, Kihlberg J (1999) MHC-restricted, glycopeptide-specific T cells show specificity for both carbohydrate and peptide residues. J Immunol 162: 4740-4744
7. Eriksson K, Bellner L, Löwhagen G-B, Tunbäck P, Rydberg K, Liljeqvist J-Å (2004) CD4+ T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type-specific and differ in symptomatic and asymptomatic HSV-2 infected individuals. J Gen Virol 85: 2139-2147
8. Forsgren M, Skoog E, Jeansson S, Olofsson S, Giesecke J (1994) Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 5: 113-116
9. Galli-Stampino L, Meinjohanns E, Frische K, Meldal M, Jensen T, Werdelin O, Mouritsen S (1997) T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity. Cancer Res 57: 3214-3222
10. Grabowska A, Jameson C, Laing P, Jeansson S, Sjogren-Jansson E, Taylor J, Cunningham A, Irving WL (1999) Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1. J Gen Virol 80: 1789-1798
11. Görander S, Svennerholm B, Liljeqvist J-Å (2003) Secreted portion of glycoprotein G of herpes simplex virus type 2 is a novel antigen for type-discriminating serology. J Clin Microbiol 41: 3681-3686
12. Hiemke C, Brunner R, Hammes E, Muller H, Meyer zum Buschenfelde KH, Lohse AW (1995) Circadian variations in antigen-specific proliferation of human T lymphocytes and correlation to cortisol production. Psychoneuroendocrinology 20: 335-342
13. Jensen T, Galli-Stampino L, Mouritsen S, Frische K, Peters S, Meldal M, Werdelin O (1996) T cell recognition of Tn-glycosylated peptide antigens. Eur J Immunol 26: 1342-1349
14. Kern F, Surel IP, Faulhaber N, Frommel C, Schneider-Mergener J, Schonemann C, Reinke P, Volk HD (1999) Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J Virol 73: 8179-8184
15. Lee FK, Coleman RM, Pereira L, Bailey PD, Tatsuno M, Nahmias AJ (1985) Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol 22: 641-644
16. Levi M, Ruden U, Wahren B (1996) Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies. Clin Diagn Lab Immunol 3: 265-269
17. Liljeqvist J-Å, Trybala E, Svennerholm B, Jeansson S, Sjögren-Jansson E, Bergström T (1998) Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J Gen Virol 79: 1215-1224
18. Liljeqvist J-Å, Svennerholm B, Bergström T (1999) Herpes simplex virus type 2 glycoprotein G-negative clinical isolates are generated by single frameshift mutations. J Virol 73: 9796-9802
19. Liljeqvist J-Å, Trybala E, Hoebeke J, Svennerholm B, Bergström T (2002) Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. J Gen Virol 83: 157-165
20. Lisowska E (2002) The role of glycosylation in protein antigenic properties. Cell Mol Life Sci 59: 445-455
21. Maecker HT, Dunn HS, Suni MA, Khatamzas E, Pitcher CJ, Bunde T, Persaud N, Trigona W, Fu TM, Sinclair E, Bredt BM, McCune JM, Maino VC, Kern F, Picker LJ (2001) Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods 255: 27-40
22. Mann DR, Akinbami MA, Gould KG, Ansari AA (2000) Seasonal variations in cytokine expression and cell-mediated immunity in male rhesus monkeys. Cell Immunol 200: 105-115
23. Marsden HS, Buckmaster A, Palfreyman JW, Hope RG, Minson AC (1984) Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J Virol 50: 547-554
24. McGeoch DJ (1987) The genome of herpes simplex virus: structure, replication and evolution. J Cell Sci Suppl 7: 67-94
25. Persson K, Månsson A, Jo̊nsson E, Nordenfeit E (1995) Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis 27: 195-199
26. Posavad CM, Wald A, Hosken N, Huang ML, Koelle DM, Ashley RL, Corey L (2003) T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity? J Immunol 170: 4380-4388
27. Su HK, Eberle R, Courtney RJ (1987) Processing of the herpes simplex virus type 2 glycoprotein gG-2 results in secretion of a 34,000-Mr cleavage product. J Virol 61: 1735-1737
28. Svennerholm B, Olofsson S, Jeansson S, Vahlne A, Lycke E (1984) Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J Clin Microbiol 19: 235-239
29. Tiefenthaler G, Hunig T (1989) The role of CD2/LFA-3 interaction in antigen- and mitogen-induced activation of human T cells. Int Immunol 1: 169-175
30. Trivedi D, Williams RY, O'Reilly RJ, Koehne G (2004) Generation of Cytomegalovirus (CMV)-specific T lymphocytes using protein-spanning pools of pp65-derived pentadecapeptides for adoptive immunotherapy. Blood, online publication Oct 28, 2004, DOI 10.1182/blood-2003-05-1433
31. Tunbäck P (2004) Thesis: Herpes simplex virus infection: Epidemiological aspects and analysis of the type-specific antibody response. Dermatology and Venereology, Göteborg University, Göteborg
32. Wedemeyer H, Mizukoshi E, Davis AR, Bennink JR, Rehermann B (2001) Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. J Virol 75: 11392-11400
33. Zeng W, Jackson DC, Murray J, Rose K, Brown LE (2000) Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens. Vaccine 18: 1031-1039